<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type='text/xsl' href='../../ld1webpage.xsl'?>
<LOBBYINGDISCLOSURE1>
  <imported>N</imported>
  <pages>2</pages>
  <regType>2</regType>
  <organizationName>Tiber Creek Health Strategies, Inc.</organizationName>
  <prefix>
  </prefix>
  <firstName>
  </firstName>
  <lastName>
  </lastName>
  <address1>1300 Connecticut Avenue, NW</address1>
  <address2>Suite 600</address2>
  <city>Washington</city>
  <state>DC</state>
  <zip>20036</zip>
  <zipext>
  </zipext>
  <country>USA</country>
  <principal_city>
  </principal_city>
  <principal_state>
  </principal_state>
  <principal_zip>
  </principal_zip>
  <principal_zipext>
  </principal_zipext>
  <principal_country>
  </principal_country>
  <contactIntlPhone>
  </contactIntlPhone>
  <registrantGeneralDescription>Government relations.</registrantGeneralDescription>
  <selfSelect>N</selfSelect>
  <clientName>Peck Madigan Jones (on behalf of Roivant Sciences, Inc.)</clientName>
  <clientAddress>1300 CONNECTICUT AVENUE, NW</clientAddress>
  <clientCity>WASHINGTON</clientCity>
  <clientState>DC</clientState>
  <clientZip>20036</clientZip>
  <clientZipExt>2003</clientZipExt>
  <clientCountry>USA</clientCountry>
  <prinClientCity>New York</prinClientCity>
  <prinClientState>NY</prinClientState>
  <prinClientZip>10018</prinClientZip>
  <prinClientZipExt>
  </prinClientZipExt>
  <prinClientCountry>USA</prinClientCountry>
  <clientGeneralDescription>Biopharmaceutical drug development.</clientGeneralDescription>
  <senateID>400712135</senateID>
  <houseID>415640020</houseID>
  <lobbyists>
    <lobbyist>
      <lobbyistFirstName>Bryant</lobbyistFirstName>
      <lobbyistLastName>Hall</lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>Staff Director, Senate Veterans Affairs Committee; Legislative Director, Senator Bob Graham
</coveredPosition>
      <lobbyistNew>Y</lobbyistNew>
    </lobbyist>
    <lobbyist>
      <lobbyistFirstName>
      </lobbyistFirstName>
      <lobbyistLastName>
      </lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>
      </coveredPosition>
      <lobbyistNew>N</lobbyistNew>
    </lobbyist>
    <lobbyist>
      <lobbyistFirstName>
      </lobbyistFirstName>
      <lobbyistLastName>
      </lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>
      </coveredPosition>
      <lobbyistNew>N</lobbyistNew>
    </lobbyist>
    <lobbyist>
      <lobbyistFirstName>
      </lobbyistFirstName>
      <lobbyistLastName>
      </lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>
      </coveredPosition>
      <lobbyistNew>N</lobbyistNew>
    </lobbyist>
    <lobbyist>
      <lobbyistFirstName>
      </lobbyistFirstName>
      <lobbyistLastName>
      </lobbyistLastName>
      <lobbyistSuffix>
      </lobbyistSuffix>
      <coveredPosition>
      </coveredPosition>
      <lobbyistNew>N</lobbyistNew>
    </lobbyist>
  </lobbyists>
  <alis>
    <ali_Code>HCR</ali_Code>
    <ali_Code>PHA</ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
    <ali_Code>
    </ali_Code>
  </alis>
  <specific_issues>Issues related to healthcare, the Food and Drug Administration, and pharmaceuticals.</specific_issues>
  <affiliatedUrl>
  </affiliatedUrl>
  <affiliatedOrgs>
    <affiliatedOrg>
      <affiliatedOrgName>
      </affiliatedOrgName>
      <affiliatedOrgAddress>
      </affiliatedOrgAddress>
      <affiliatedOrgCity>
      </affiliatedOrgCity>
      <affiliatedOrgState>
      </affiliatedOrgState>
      <affiliatedOrgZip>
      </affiliatedOrgZip>
      <affiliatedOrgCountry>
      </affiliatedOrgCountry>
      <affiliatedPrinOrgCity>
      </affiliatedPrinOrgCity>
      <affiliatedPrinOrgState>
      </affiliatedPrinOrgState>
      <affiliatedPrinOrgCountry>
      </affiliatedPrinOrgCountry>
    </affiliatedOrg>
    <affiliatedOrg>
      <affiliatedOrgName>
      </affiliatedOrgName>
      <affiliatedOrgAddress>
      </affiliatedOrgAddress>
      <affiliatedOrgCity>
      </affiliatedOrgCity>
      <affiliatedOrgState>
      </affiliatedOrgState>
      <affiliatedOrgZip>
      </affiliatedOrgZip>
      <affiliatedOrgCountry>
      </affiliatedOrgCountry>
      <affiliatedPrinOrgCity>
      </affiliatedPrinOrgCity>
      <affiliatedPrinOrgState>
      </affiliatedPrinOrgState>
      <affiliatedPrinOrgCountry>
      </affiliatedPrinOrgCountry>
    </affiliatedOrg>
    <affiliatedOrg>
      <affiliatedOrgName>
      </affiliatedOrgName>
      <affiliatedOrgAddress>
      </affiliatedOrgAddress>
      <affiliatedOrgCity>
      </affiliatedOrgCity>
      <affiliatedOrgState>
      </affiliatedOrgState>
      <affiliatedOrgZip>
      </affiliatedOrgZip>
      <affiliatedOrgCountry>
      </affiliatedOrgCountry>
      <affiliatedPrinOrgCity>
      </affiliatedPrinOrgCity>
      <affiliatedPrinOrgState>
      </affiliatedPrinOrgState>
      <affiliatedPrinOrgCountry>
      </affiliatedPrinOrgCountry>
    </affiliatedOrg>
  </affiliatedOrgs>
  <foreignEntities>
    <foreignEntity>
      <name>Roivant Sciences Ltd.</name>
      <address>Clarendon House - 2 Church Street</address>
      <city>Hamilton</city>
      <state>
      </state>
      <country>BER</country>
      <prinCity>
      </prinCity>
      <prinState>
      </prinState>
      <prinCountry>
      </prinCountry>
      <contribution>0</contribution>
      <ownership_Percentage>100</ownership_Percentage>
    </foreignEntity>
    <foreignEntity>
      <name>Roivant Sciences Holdings Ltd.</name>
      <address>20-22 Bedford Row</address>
      <city>London</city>
      <state>
      </state>
      <country>GBR</country>
      <prinCity>
      </prinCity>
      <prinState>
      </prinState>
      <prinCountry>
      </prinCountry>
      <contribution>0</contribution>
      <ownership_Percentage>100</ownership_Percentage>
    </foreignEntity>
  </foreignEntities>
  <reportYear>2018</reportYear>
  <reportType>RR</reportType>
  <effectiveDate>4/18/2018</effectiveDate>
  <printedName>Bryant Hall, President</printedName>
  <signedDate>5/31/2018 11:39:45 AM</signedDate>
</LOBBYINGDISCLOSURE1>